Shruti Gupta (@shrutigkidney) 's Twitter Profile
Shruti Gupta

@shrutigkidney

Mom, Wife, Director of Onconephrology at BWH/DFCI. Founder of American Society of Onconephrology. Assistant Prof at HMS. Exercise and wine enthusiast

ID: 1039881461061640192

linkhttps://www.shrutigkidney.org/ calendar_today12-09-2018 14:20:35

359 Tweet

884 Followers

312 Following

Kenar Jhaveri (@kdjhaveri) 's Twitter Profile Photo

New "X"orial alert 1/ What medications, if any, do you give to prevent cisplatin-associated acute kidney injury (CP-AKI )? A new paper in JAMA Oncology led by Shruti Gupta and David Leaf found that IV magnesium may reduce the risk of CP-AKI. Here’s a brief #tweetorial

Blood Journal (@bloodjournal) 's Twitter Profile Photo

🚨New Blood issue out now featuring: Glucarpidase for treatment of high-dose methotrexate toxicity ow.ly/QlV750VHfxn @ShrutiGKidney @SarahKaunfer David Leaf

🚨New Blood issue out now featuring:
Glucarpidase for treatment of high-dose methotrexate toxicity ow.ly/QlV750VHfxn
@ShrutiGKidney @SarahKaunfer <a href="/DavidLeaf9/">David Leaf</a>
Blood Journal (@bloodjournal) 's Twitter Profile Photo

In patients with MTX-AKI, glucarpidase was associated with a higher adjusted odds of kidney recovery and faster time to kidney recovery. ow.ly/GaEn50VHuKC #clinicaltrialsandobservations @ShrutiGKidney @SarahKaunfer David Leaf

In patients with MTX-AKI, glucarpidase was associated with a higher adjusted odds of kidney recovery and faster time to kidney recovery. ow.ly/GaEn50VHuKC #clinicaltrialsandobservations @ShrutiGKidney @SarahKaunfer <a href="/DavidLeaf9/">David Leaf</a>
Mass General Brigham Research (@mgbresearchnews) 's Twitter Profile Photo

In a new study, researchers from The Brigham Nephrology @harvardmed and colleagues found that IV magnesium reduces kidney damage from cisplatin chemotherapy. The study was published in JAMA Oncology. Read more: massgeneralbrigham.org/en/about/newsr… Shruti Gupta David Leaf

In a new study, researchers from <a href="/BWHKidney/">The Brigham Nephrology @harvardmed</a> and colleagues found that IV magnesium reduces kidney damage from cisplatin chemotherapy. The study was published in <a href="/JAMAOnc/">JAMA Oncology</a>. 

Read more: massgeneralbrigham.org/en/about/newsr… <a href="/ShrutiGkidney/">Shruti Gupta</a> <a href="/DavidLeaf9/">David Leaf</a>
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Most viewed this week from JAMA Oncology: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. ja.ma/44fFHqa

Most viewed this week from <a href="/JAMAOnc/">JAMA Oncology</a>: 

Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. 

ja.ma/44fFHqa
Elad Sharon (@eladsharonmd) 's Twitter Profile Photo

Proud to say that I work quite closely with the first author of this important article… Dr Shruti Gupta: protecting the kidneys from those oncology drugs. Your work is never done!

ASN Publications (@asnpublications) 's Twitter Profile Photo

In a #ASNCJASN perspective, physicians from Brigham and Women's Hospital discuss their recently launched inpatient onconephrology consult service, similar to cardio-renal services, which provides specialized care to patients at Dana-Farber Cancer Institute.

In a #ASNCJASN perspective, physicians from Brigham and Women's Hospital discuss their recently launched inpatient onconephrology consult service, similar to cardio-renal services, which provides specialized care to patients at Dana-Farber Cancer Institute.
Raad Chowdhury, MD, FASN (@rc_oncneph) 's Twitter Profile Photo

Last wk was the Gupta Lab soiree hosted by Shruti Gupta to congratulate her incoming and outgoing research assistants, they help move onconeph forward. Many of the RAs are headed to some pretty awesome med schools, kudos to Shruti's mentorship! American Society of Onconephrology The Brigham Nephrology @harvardmed

Last wk was the Gupta Lab soiree hosted by <a href="/ShrutiGkidney/">Shruti Gupta</a> to congratulate her incoming and outgoing research assistants, they help move onconeph forward. Many of the RAs are headed to some pretty awesome med schools, kudos to Shruti's mentorship!
<a href="/onconephsociety/">American Society of Onconephrology</a> 
<a href="/BWHKidney/">The Brigham Nephrology @harvardmed</a>
Chennai Kidney Associates (@chennaikidney) 's Twitter Profile Photo

Meet the distinguished faculty of the ISN-SAARC Onconephrology Course 2025! Their commitment to knowledge-sharing is instrumental in advancing kidney and cancer care. #Onconephrology2025 #ISNSAARC #MedicalEducation #KidneyHealth #CancerCare

Meet the distinguished faculty of the ISN-SAARC Onconephrology Course 2025!
Their commitment to knowledge-sharing is instrumental in advancing kidney and cancer care.
#Onconephrology2025 #ISNSAARC #MedicalEducation #KidneyHealth #CancerCare
Mayo Clinic Nephrology (@mayoclinicneph) 's Twitter Profile Photo

Mayo Clinic is pleased to announce a two-day course on Sept 11-12, the Onco-Nephrology Symposium 2025, introduces the latest updates & advances in the field of onco nephrology. Please join us for this exciting event! To learn more, click here ce.mayo.edu/nephrology/con…

Mayo Clinic is pleased to announce a two-day course on Sept 11-12, the Onco-Nephrology Symposium 2025, introduces the latest updates &amp; advances in the field of onco nephrology. Please join us for this exciting event! To learn more, click here ce.mayo.edu/nephrology/con…
Shruti Gupta (@shrutigkidney) 's Twitter Profile Photo

Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis - An amazing 3- center collaboration! ⁦Mass General Brigham Nephrology⁩ ⁦American Society of Onconephrology⁩ ⁦meg sise⁩ ⁦Dennis Moledina, MD PhD⁩ Kavita Mistry sciencedirect.com/science/articl…

Nattawat Klomjit (@basmeomeo) 's Twitter Profile Photo

1.Hypomagnesemia is common in cancer patients and anti-cancer therapy is one of the main causes, but what are those meds and characteristics of patients? Our recent study tries to answer these questions. ejinme.com/article/S0953-… Shruti Gupta meg sise Kenar Jhaveri American Society of Onconephrology